| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
CARCINOMA DELL’ENDOMETRIO STADI PRECOCI I-II E AVANZATI III E IV VALUTAZIONE DI POLE COME FATTORE PROGNOSTICO |
NA |
in corso |
CARCINOMA DELL’ENDOMETRIO |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
MULTIOMIC ANALYSIS TO DEVELOP A PREDICTIVE SIGNATURE IN PLEURAL MESOTHELIOMA. A PROSPECTIVE OBSERVATIONAL STUDY (PNRR-TR1-2023-12377102) |
NA |
in corso |
mesotelioma pleurico |
- SC Oncologia Clinica Sperimentale Toraco - Polmonare |
|
A PHASE III, OPEN-LABEL, RANDOMIZED, ACTIVE-CONTROLLED, MULTI-CENTRE TRIAL EVALUATING ORALLY ADMINISTERED ZONGERTINIB (BI 1810631) COMPARED WITH STANDARD OF CARE AS FIRST-LINE TREATMENT IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC NONSQUAMOUS NON-SMALL CELL LUNG CANCER HARBOURING HER2 TYROSINE KINASE DOMAIN MUTATIONS |
III |
in corso |
NSCLC |
- SC Oncologia Clinica Sperimentale Toraco - Polmonare |
|
Impiego della Radiomica spaziale e trascrittomica per indagare il cross-talk tra cancro del colon e malattia renale cronica - PNRR-MCNT1-2023-12378005 |
NA |
in corso |
cancro del colon |
SC Radiodiagnostica - |
|
A PHASE III, OPEN-LABEL, SPONSOR-BLIND, RANDOMIZED STUDY OF DATO-DXD WITH OR WITHOUT OSIMERTINIB VERSUS PLATINUM-BASED DOUBLET CHEMOTHERAPY FOR PARTICIPANTS WITH EGFR-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON PRIOR OSIMERTINIB TREATMENT |
III |
in corso |
Carcinoma polmonare non a piccole cellule |
- SC Oncologia Clinica Sperimentale Toraco - Polmonare |
